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Abstract
A qualitative botanical identification method (BIM) is an analytical procedure that returns a binary
result (1 = Identified, 0 = Not Identified). A BIM may be used by a buyer, manufacturer or
regulator to determine whether a botanical material being tested is the same as the target (desired)
material, or whether it contains excessive non-target (undesirable) material. The report describes
the development and validation of studies for a BIM based on the proportion of replicates
identified, or probability of identification (POI), as the basic observed statistic. The statistical
procedures proposed for data analysis follow closely those of the probability of detection, and
harmonize the statistical concepts and parameters between quantitative and qualitative method
validation. Use of POI statistics also harmonizes statistical concepts for botanical,
microbiological, toxin, and other analyte identification methods that produce binary results. The
POI statistical model provides a tool for graphical representation of response curves for qualitative
methods, reporting of descriptive statistics, and application of performance requirements. Single
collaborator and multicollaborative study examples are given.
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A botanical is an herbal material that is frequently used as an ingredient in a dietary
supplement regulated in the United States under the Federal Food, Drug, and Cosmetic Act
of 1938, as amended by the Dietary Supplement Health and Education Act of 1994 (1).
More recently, current Good Manufacturing Practices for foods and dietary supplements (2)
issued by the U.S. Food and Drug Administration has tasked manufacturers with
establishing specifications and developing a QA program for all botanical ingredients. As a
consequence, both processors of botanicals and regulators are interested in the verification
of the identity of botanical materials. Thus, the development of reliable methods for the
identification of botanical materials and minimum acceptable levels of contamination are
critical.
A botanical identification method (BIM) is any qualitative method that reliably identifies a
botanical material and returns a binary result of either 1 = “identified” or 0 = “not
identified.” The actual method used can be presumed unknown and a “black box” with
respect to the protocols involved in the validation studies. The BIM must be validated in
terms of inclusivity, exclusivity, probability of identification, robustness, reproducibility,
repeatability, and other criteria.
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The heart of the BIM is the probability of identification (POI) model. The POI model has
been developed as a means of characterizing and validating the performance of a qualitative
method based on simple statistics and associated confidence intervals (3, 4). Figure 1
(modified from ref. 3) shows a plot where the concentration of the target material increases
towards the right while the concentration of a non-target material increases to the left. The
parameter of interest is the POI (the vertical axis), which is defined as the probability, at a
given percentage of target material, of getting a positive response by the detection method.
The positive response of the BIM indicates that the test material matches the target botanical
material. While the plot in Figure 1 is symmetrical, POI plots are usually asymmetrical. The
POI model is based on the probability of detection model which was developed for binary
qualitative methods (3, 4).
The POI, as illustrated in Figure 1, is dependent on the concentration of the target botanical
material. The probability of a positive response increases as the concentration of the target
botanical increases and decreases as the concentration of the non-target material increases.
The goal of method development and validation is primarily to determine if the method
meets method performance requirements (MPRs), and secondarily to characterize how the
method makes the transition from a negative to a positive response.
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The MPRs, as established by the developer, will specify the target botanical materials
(inclusivity sampling frame; ISF), the non-target materials (exclusivity sampling frame;
ESF), the physical form of the materials, the minimum concentration of target material that
is acceptable in the presence of nontarget material, and the maximum concentration target
material that is unacceptable. These latter materials are the specific superior and specific
inferior test materials (SSTM and SITM, respectively). The idealized goal of the BIM is to
discriminate (with a specified degree of confidence, e.g., 95%) between the SSTM (for
which the POI is high) and the SITM (for which the POI is low). Additionally, samples of
the SSTM and SITM may be mixed to obtain the intermediate test concentrations that are
used to characterize the POI curve in its transitional range.
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In some studies, full characterization of the transition of the POI curve may be of lesser
importance and the intermediate concentrations omitted. In this care the only concentrations
used are those for which the performance requirements are applied, typically the SITM and
SSTM (0% and 100% SSTM, respectively). Two factors are important to method
development: industrial-regulatory requirements, and the technological limit (state of the
measurement art). If the technological limit exceeds the industry-regulatory requirement,
then the industrial-regulatory requirement can be set at a value reasonably attainable by
existing technology. In this case, the cost of the analysis may be the major factor governing
validation study design. If the technological limit cannot meet the industrial-regulatory
requirement, then improved technology must be developed before a BIM fit for the purpose
intended can be found.

Glossary
Analytical parameter (AP).—A measured or computed analytical value used to determine
whether the test material matches the target material. The analytical parameter may be based
on morphological features, genetic sequences, chromatographic patterns, spectral patterns,
or any other metric appropriate for the target material.
Botanical.—Of or relating to plants or botany. May also include algae and fungi. May refer
to the whole plant, a part of the plant (e.g., bark, woods, leaves, stems, roots, rhizomes,
flowers, fruits, seeds, extracts, etc.), or an extract of the plant.
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BIM.—A method that establishes identity specifications for a botanical material and
determines, within a specified statistical limit, a binary result: yes, the test material is a true
example of the target botanical material and meets the identity specifications; or no, it is not
the target botanical. Thus, a BIM answers the question, “Is the test material the same as the
target material?” not “What is this material?” In most cases, the method will achieve this
goal by comparison of the test material with materials from the inclusivity panel and will
return a yes/no (or, in some cases, a consistent/non-consistent) answer.
Candidate method.—The method to be validated.
Exclusivity.—Ability of a BIM to correctly reject non-target botanical materials.
ESF.—A list of practically obtainable non-target botanical materials that have similar
taxonomic, physical, or chemical composition characteristics that are expected to give a
negative result when tested by the BIM.
Exclusivity panel.—A subset of the ESF that is selected for the validation study. These
materials should be authenticated by an appropriate method.
False-negative fraction (FNF).—1–POI for 100% SSTM. Not defined for other
concentrations.
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False-positive fraction (FPF).—POI for 100% SITM. Not defined for other concentrations.
Identity specification.—The morphological, genetic, chemical, or other characteristics that
define a target botanical material. Specifications may include, but are not limited to, data
from macroscopic, microscopic, genetic (e.g., DNA sequencing, barcoding),
chromatographic fingerprinting (e.g., CE, GC, LC, TLC), and spectral fingerprinting (e.g.,
IR, NIR, NMR, MS, UV-Vis) methods.
Inclusivity.—Ability of a BIM to correctly identify variants of the target material that meet
the identity specification.
ISF.—A list of practically obtainable botanical materials that are expected to give a positive
result when tested by the BIM. The inclusivity sampling frame should be sufficiently large
that the botanical variation is adequately represented. Sources of variation may include, but
are not limited to, species, subspecies, cultivar, growing location, growing conditions,
growing season, and post-harvest processing.

NIH-PA Author Manuscript

Inclusivity panel.—A subset of the ISF that is selected for the validation study. These
materials should be authenticated by an appropriate method.
Laboratory sample.—Sample as prepared for sending to the laboratory intended for
inspection or testing.
MPRs.—Performance requirements based on the fitness for purpose statement for each
method. For BIMs, the MPRs should minimally include the physical form of the sample, the
ISF, the ESF, the SSTM, and the SITM.
Non-target botanical material.—Any botanical material that does not meet the identity
specification.
Physical form.—Botanical materials exist in a number of physical forms. The form(s) to be
analyzed by the method will be specified by the MPRs.
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POI.—The expected or the observed fraction of test portions that provide a positive result at
a given concentration when tested by the BIM.
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Sample.—A small quantity, taken from a population or lot that is a representative selection
of the whole.
SITM.—A mixture of botanical materials that contains the maximum concentration of target
material that is considered unacceptable, as specified by the MPRs. The BIM must reject
this material with a specified minimum level of (1–POI) with 95% confidence. The ideal
BIM would reject the SITM 100% of the time (i.e., identify 0% of the time). The SITM will
typically be high-quality target material mixed with worst-case (for identification) nontarget material.
SSTM.—A mixture of botanical material that contains the minimum acceptable
concentration of the target material, as specified by the MPR. The BIM must identify this
material with a specified minimum level of POI with 95% confidence. The ideal BIM would
identify the SSTM 100% of the time. The SSTM will typically be high-quality target
material mixed with a small amount of worst-case (for identification) non-target material.
Target botanical material.—The botanical material of interest as described in the identity
specification.
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Target material concentration.—The percentage, by weight, of the target botanical material
in the sample.
Test portion.—The portion of the laboratory sample that is subjected to analysis by the
method.

Inclusivity Panel
When a botanical material is identified for development of a BIM, a target material is
usually specified. Biological materials, however, are complex. While the genotype of a
species or subspecies may be relatively stable, the phenotype (metabolite composition) will
vary with location, season, weather, and many other variables. Thus, “target material”
becomes “target materials.” Ideally, the target materials will encompass the expected
botanical variation.
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An inclusive list of all the variations for a target material can be quite extensive and
impractical. For example, the list for a specific botanical might ideally include samples from
the last 10 years from eight international locations (80 samples). In reality, only 25 of the
desired samples may be practically obtainable. These 25 obtainable samples comprise the
ISF. Of these 25 samples, only 10 may be selected for method development/validation.
These 10 samples comprise the inclusivity panel.
For each candidate BIM, the MPRs must provide a list of all necessary botanical variants
that should provide a positive identification. This should include species, varieties,
geographic or seasonal variants, and other variants that are believed to possibly associate
with BIM identification performance. The information tabulated should include variety,
season, locality, source from which the variant is obtainable, species, variety or subclass,
and whether or not it is essential that the variant be tested. The age of the plant may also be a
factor of importance. The subset of this list, which is practically obtainable for a validation
study, is the ISF.
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The MPRs should identify the minimum number of materials in the ISF that must be tested
to verify identifiability (inclusivity panel), as well as the number of replicates needed. If at
all possible, any exchangeability (choice among variants which MPRs do not discriminate)
should result in random selection from the ISF.
Generally, the inclusivity panel of target variants should include all of the ISF if the number
of variants is small. Otherwise, all necessary variants plus additional ones randomly selected
should comprise the inclusivity panel. More randomized replicate variants may allow a
quantitative statistical inference to be made concerning inclusivity. An inclusivity panel with
no randomization, only subjective selection, does not permit statistical statements of
inference with respect to inclusivity.

Exclusivity Panel
The list of non-target materials can be quite extensive, theoretically including all the
botanicals not on the inclusivity list. However, of prime interest are those materials that
might accidentally or intentionally be used to replace or augment the target materials. The
exclusivity list should include botanical materials that are closely related taxonomically,
morphologically, or phenotypically. Again, this list may be extensive and impractical. The
ESF will comprise those botanical materials that are practically obtainable. The exclusivity
panel will comprise those samples used for method development and validation.
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The MPRs must provide a list of all necessary or commonly encountered non-target
botanical materials and variants. This list should include botanical materials that are
believed to accidentally or intentionally alter the composition of the target material. The
information tabulated should include variety, season, locality, source from which the variant
is obtainable, species, variety or subclass, and whether or not it is essential that the nontarget material be tested. The subset of this list, which is practically obtainable for a
validation study, should then be identified as the ESF.
The MPRs should identify the minimum number of non-target materials of the ESF that
should be included on the exclusivity panel and be tested to verify non-identifiability, as
well as the number of replicates needed. If at all possible, any exchangeability (choice
among variants which expertise does not discriminate) should result in random selection
from the ESF.
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Generally, the exclusivity panel of authentic variants should include all of the ESF if the
number of variants is small. Otherwise, all necessary variants, plus optional ones randomly
selected, should comprise a set as specified by the ERP. More replicates and randomization
may allow a quantitative statistical inference to be made concerning exclusivity.

Inclusivity and Exclusivity Testing
The purpose of inclusivity/exclusivity testing is to verify that the BIM correctly identifies all
of the botanical materials listed in the ISF and correctly rejects all non-target materials listed
in the ESF. The BIM should clearly and unequivocally discriminate between the target and
non-target materials. Testing materials from the inclusivity/exclusivity panels should
provide sufficient confidence that this is the case. The number of samples tested and the
number of replicates is specified by the MPRs.
Typically, inclusivity/exclusivity panel results are verified during method development. Any
unexpected results should be followed up with a minimum number of additional replications
(determined by the MPRs) to characterize the POI on the variant quantitatively. If the
variant fails to meet minimum acceptable performance requirements as set by the MPRs, the
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exception should be noted in the study report and reviewed for acceptability by the relevant
method reviewers.
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If the method development results are acceptable, inclusivity and exclusivity should be
verified in an independent laboratory, although possibly on a less-intensive (fewer replicates
or randomly selected variants) basis, as the objective is verification, not validation. If no
randomization is used, all that can be reported are the actual results obtained, but without
suggestive quantitative statistics. For example, without randomization, the use of
percentages or other quantitative measures is inappropriate.

Performance Requirements and the Specification and Preparation of the
SITM and SSTM
After inclusivity and exclusivity studies have been completed, target and non-target
material(s) are chosen to verify that the method can discriminate between the SSTM and the
SITM. Either the worst-case non-target materials, or perhaps the most common non-target
materials, would typically be chosen. In addition, a combination of target and non-target
materials should be selected to challenge method performance (worst-case, most common,
etc.). The number of samples tested and the number of replicates is specified by the MPRs.
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The MPRs should identify the composition and the minimum POI acceptable (with 95%
confidence) for the SSTM and SITM. The SSTM and SITM would be made of the target
material(s) mixed with the combination of non-target material(s).

Application of the POI to an Analytical Method
Analytically, a BIM will be based on a series of measured values. These values may be
derived from morphological features, genetic sequences, chromatographic patterns, spectral
patterns, or any other metric appropriate for the target material. These values will be
combined to provide a single AP that will be used to determine whether the test sample does
or does not match the materials from the inclusivity panel. This decision is made by
comparing the AP of the test material to a threshold value that provides the level of
identification specified by the MPRs.
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The first step in the development of the method is the selection of the analytical approach
and the analysis of samples from the ISF and ESF. Multiple replicates of multiple samples
should, ideally, give results similar to those in Figure 2. Here, the AP, not the POI, is plotted
on the vertical axis. The standard deviations (SDs) are shown as sample distribution
functions, rather than as error bars. Ideally, the separation of the ISF and ESF samples
should be as large as possible. For the data in Figure 2, the threshold to distinguish between
the ISF and ESF can be placed at almost any value of the AP.
The width of the sample distribution function will depend on the number of samples
analyzed from the ISF and ESF. If replicates of a single sample are analyzed, then the width
of the distribution will be narrow (a smaller SD), and only reflect the instrumental variance.
As more samples are analyzed from the ISF and ESF, the distribution functions will
broaden, reflecting the increasing biological variance.
The next step is to determine whether the method can distinguish between the SSTM and the
SITM. The concentrations of the SSTM and the SITM are specified by the MPRs. Figure 2
illustrates an arbitrary specification. It can be seen that the distributions of the SSTM and
SITM are completely resolved and the threshold must be located exactly between the two
distributions to provide 100% identification of the SSTM (POI = 1) and 100% rejection of
the SITM (POI = 0). If the concentration of target material in the SSTM was lower, or the
J AOAC Int. Author manuscript; available in PMC 2013 April 08.
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concentration in the SITM higher, the distribution functions would overlap and 100%
identification or rejection would not be possible. In this case, the confidence limit would
have to be lowered or another method selected.
Finally, the shape of the POI curve can be determined. As shown in Figure 3, concentrations
of the target materials that fall between the SSTM and SITM must be prepared. In each case,
the threshold will intersect each peak and determine the POI. As the SSTM:SITM values
change from 1:0 to 3:1 to 1:1 to 1:3 to 0:1, the POI decreases from 1.0 to 0.9 to 0.5 to 0.1 to
0.0.
The models in Figures 2 and 3 assume that the SITM and SSTM have the same, symmetrical
distribution function and width. This is not a reasonable assumption for real samples.
However, the POI model is valid regardless of the shape of the distribution functions
involved.

A Specific Example: American Ginseng Mixed with Asian Ginseng
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The data set presented here illustrates the analytical measurements discussed in the previous
section. The target botanical material is American ginseng (AG) and the non-target material
is Asian ginseng (CG). The inclusivity panel consists of 43 AG samples grown in the United
States (harvested over 3 years from 20 different farms in Wisconsin), and the exclusivity
panel consists of eight CG samples grown in China (Table 1).
The AG and CG samples were analyzed by direct injection MS, and yielded spectra with
approximately 1000 ions. The SSTM and SITM were generated synthetically by combining
different percentages of the AG and CG mass spectra. For example, the spectra for 98% AG
mixed with 2% CG was computed as 0.98 of an AG spectra added to 0.02 of a CG spectra.
In all, 344 SSTM spectra were generated (43 AG × 8 CG).
The multivariate data set (395 samples × 1000 variables) was analyzed using soft
independent modeling of class analogy (SIMCA; Appendix A). SIMCA fit a principal
component model to the data for the inclusivity panel (100% AG) and produced a goodnessof-fit value, the Q residual, for every sample analyzed. The Q residual was used to compare
the test (100% CG, SSTM, and SITM) and the target (100% AG) materials. In every case,
the SIMCA model was based on 100% AG and a single principal component. The Q
residual describes how far a sample falls outside the model (Appendix A).
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Figure 4A shows the inclusivity/exclusivity study. The Q residual is plotted for individual
samples. With 100% AG (inclusivity panel samples) as the model, the CG (exclusivity panel
samples) falls well above the 95% confidence limit (dashed line). Both the AG and CG
show considerable variation on the vertical axis, which reflects biological variation. Two of
the AG samples fall above the 95% confidence limit, which is 4.6% for 43 samples and is to
be expected.
For the SSTM/SITM study, 98 and 90% AG were arbitrarily selected as the MPRs for this
model. Figure 4B shows the SSTM samples (98% AG), as well as 100% AG and 100% CG
samples. The pattern of eight groupings for the SSTM samples reflects that all 43 AG
samples were diluted by each of the eight CG samples in sequence. A threshold of a Q
residual value of 9.0 was selected arbitrarily and provides 99.4% positive identification (342
out of 344).
Figure 4C shows the SITM at 90% AG. The threshold provides negative identification of the
SITM for 99.1% of the samples (341 out of 344). The distribution of the SSTM and SITM
are plotted in Figure 5A. The distributions appear to be roughly symmetrical. However,
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since the vertical axis is a logarithmic scale, the distributions are badly skewed on a linear
scale and have dramatically different widths. If the SSTM were specified at a lower
concentration of AG, or the SITM at a higher concentration, the method would not be
appropriate unless lower confidence limits were chosen.
Based on the AP threshold shown in Figures 4B, 4C, and 5, the POI in Figure 5B was
computed. Synthetic samples of 96, 94, and 92% were generated and analyzed. The curve
shape for the POI is very non-symmetric.
For our example, the SSTM corresponds to 98% AG mixed with 2% CG. The required
minimum POI is 0.90, with 95% confidence for 100% SSTM (Table 2). The SITM
corresponds to 90% AG mixed with 10% CG. The required maximum POI is 0.10, with
95% confidence. Table 2 shows that, for these performance requirements, 60 replicates must
be tested at each level with no more than two failures. More stringent requirements (i.e.,
0.95 and 0.05, with 95% confidence) would require more replicates and/or fewer failures.
Conversely, less-stringent requirements would require fewer replicates. Depending upon the
desired performance requirement for SSTM or SITM, alternative test plans (confidence
levels) may be selected from Table 3. For more plans, see LaBudde (5).

Single-Laboratory Validation
NIH-PA Author Manuscript

Consider an example of a BIM being evaluated with respect to the performance
requirements of Table 2. The internal operating methodology of the BIM is possibly a tradesecret of the method developer, and may not be known at the time of validation. All that is
known for sure is that a test portion is utilized by the method, and binary result of yes =
Identified or no = Not Identified is returned.
Consider testing in a single independent laboratory, or a SLV. With respect to the
performance requirements of Table 2, the SITM and SSTM are used to prepare mixtures in
the proportions 0:100%, 33:67%, 67:33%, and 100:0%. From each of these mixtures, 60 test
portions are prepared, randomized, and labeled in a masked way. The test portions are
measured by the BIM, each with a result of 0 or 1. Suppose example results are as shown in
Table 4. Note the FPF performance requirement succeeds at 0% SSTM, because no more
than two test portions reported identification. Also, the FNF performance requirement at
100% SSTM succeeds because, in both cases, fewer than two test portions were not
identified.
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Using the methods of Wehling et al. (3) and LaBudde (6, 7), the reported 1-sided and 2sided 95% confidence intervals on the POI would be as shown in Table 5. Note that the 1sided 95% confidence limit for the POI falls below 10% at 0% SSTM, and above 90% at
100% SSTM, indicating performance requirement success. The results in Table 5 are plotted
in Figure 6.
Because the concentrations (% SSTM) are known with certainty here, one of several
regression models might be fit to possibly obtain more precise estimates of POI and its
confidence limits (although this is not guaranteed), but at the expense of some additional
assumptions (see Appendix B).

Collaborative Study
The primary purpose of a collaborative study is to establish that performance is reproducible
among different collaborators (laboratories). A secondary purpose might be to compare the
candidate method to another (possibly gold standard) method to establish differential
performance (e.g., equivalency) across laboratories.

J AOAC Int. Author manuscript; available in PMC 2013 April 08.
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The primary purpose requires a minimum number of collaborators whose data persist (i.e.,
not excluded for cause) until the final results of the study. Rules of thumb in statistical
mixed modeling (treating the collaborator effect as random) suggest that fewer than six
collaborators does not allow inference with respect to the general collaborator population,
eight collaborators allows reasonable estimation, and 10 collaborators is desirable. More
than 10 collaborators is useful, but not necessary. For fewer than six collaborators, the
collaborator effect should be regarded as fixed, and any inferences are applicable only to
that particular set of collaborators, not some hypothetical general population of
collaborators. The recommendation, therefore, is that 12 or more collaborators should be
enrolled in the study, with a desired 8 to 10 remaining after removal for cause, and an
absolute limit of no fewer than six remaining until the study end. Studies with this minimum
number of collaborators can hope to provide a measure of collaborator effect or
collaborator-method interaction, if one of reasonably large size exists.
Concentration levels (i.e., percentage of SSTM in a SSTM:SITM mixture) must include 0%
SSTM (100% SITM) and 100% SSTM (0% SITM) in order to establish performance
requirements (Figure 2). In addition, it is sometimes beneficial to provide for two
intermediate concentrations (e.g., 33 and 67%) in order to provide information about
identification performance across the range where the POI changes.
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In order to isolate a collaborator effect in the presence of quantal noise (repeatability error),
12 replicates per collaborator is the suggested minimum. Therefore, the smallest acceptable
collaborative study final data would be six collaborators × 12 replicates = 72 test portions.
It should be noted that due to the inter-collaborator variation, a performance requirement
imposed on a collaborative study will be more difficult for a candidate BIM to achieve than
that imposed on an SLV study with the same number of total replicates. The performance
requirements imposed on a single laboratory study and a collaborative study should be
logically and statistically consistent.
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The study director could, for example, prepare batches of SITM and SSTM, then prepare
samples of mixtures at the 0:100%, 33:67%, 67:33%, and 100:0% proportions. From each of
the well-mixed sample aliquots, test portions would be selected, such that each participating
collaborator would receive the requisite number of replicates (see section on SLV). All test
portions for each collaborator would be randomly assigned IDs before distribution. The
study is masked so that collaborators cannot visually identify the composition of the test
portions. Additional unmasked test portions may be provided for proficiency training
purposes. Each collaborator would use the BIM according to instructions to analyze each
test portion provided, and report results by test portion number and 1 = Identified or 0 = Not
Identified.
Suppose a collaborative study is to be evaluated with respect to the performance
requirements of Table 2. The primary goal is to validate that performance is sufficiently
homogeneous across collaborators and that the performance requirements are met. As
mentioned before, the number of replicate test portions for each collaborator should be 12 or
more to control the quantal repeatability error sufficiently to allow detection of an
intercollaborator effect. Suppose the plan was to enroll 12 collaborators, with the
expectation that on or two might have to be removed for cause (spoilage of test portions,
failing to follow instructions, cross-contamination, etc.) Consequently 144 test portions are
prepared for each of the four % SSTM values (0, 33.3, 66.7, and 100%).
After completion of the study, two collaborators are removed for cause, and the results
shown in Table 6 are obtained. For the 0% SSTM concentration, the statistical analysis of
the data gives the results in Table 7. There is no detected intercollaborator effect (P-value =
J AOAC Int. Author manuscript; available in PMC 2013 April 08.

LaBudde and Harnly

Page 10

NIH-PA Author Manuscript

0.43, point estimate = 0.00, confidence interval includes 0.000 and has an upper limit of
0.040), and the upper 2-sided confidence limit for combined POI is 0.0457, well below the
performance requirement of 0.10. There is little evidence that the method is irreproducible,
and the method meets the POI (or FPF) performance requirement.
For the 33% SSTM concentration, the statistical analysis of the data gives the results in
Table 8. Again, there is no detected intercollaborator effect (P-value = 0.66), so there is little
evidence that the method is irreproducible.
For the 67% SSTM concentration, the statistical analysis of the data gives the results in
Table 9. Once again, there is no detected intercollaborator effect (P-value = 0.18), so there is
little evidence that the method is irreproducible.
Finally, for the 100% SSTM concentration, the statistical analysis of the data gives the
results in Table 10. There is no detected intercollaborator effect (P-value = 0.25, point
estimate = 0.027, confidence interval includes 0.000 and has an upper limit of 0.093), and
the lower 2-sided confidence limit for combined POI is 0.917, well above the performance
requirement of 0.90. There is little evidence that the method is irreproducible, and the
method meets the POI (or FNF) performance requirement.

Lot-Lot Variability, Time Stability, and Robustness Studies
NIH-PA Author Manuscript

The SLV and collaborative studies discussed above do not represent worst-case, end-of-life
conditions with respect to method materials and parameters. For this reason, it is customary
to augment these studies with additional studies to verify proper results despite reasonable
variations among method materials, equipment, and parameters.
A lot-lot variability study is meant to verify results across different lots of method materials
(supplies used) and sets of equipment. Each lot would consist of a different manufactured or
prepared batch of materials (reagents, supplies, etc.), and possibly a different set of
measurement equipment. Date of manufacture is not an issue in this study, only variation
among lots, so ideally, the lots tested should have been produced at near the same times. Just
as with collaborators in a collaborative study, estimation of the lot random effect requires
that at least six different lots be involved in the study. Each lot should result in attainment of
any BIM performance requirements, and the variation in performance among lots should be
immaterial in size.
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A time stability study is meant to verify that there is no material degradation in performance
over the life of lots of materials and equipment. This may be accomplished by determination
of the parametric aging effect by use of time-staggered lots, or simply verifying performance
on end-of-life lots.
Note that the lot-lot variability and time-stability studies cannot be merged into a single
study unless there are sufficient replicate lots at or near the same time point(s) to allow
separation of the lot-lot and time effects. If lot-lot and time effects are negatively correlated,
one factor may mask the effect of the other in an inadequate combined study (e.g., a
different single lot at each different time point). Testing only end-of-life lots would be a
satisfactory combined study, even though time and lot effects could not be resolved.
A robustness study (also denoted a sensitivity study) is meant to verify performance under
worst-case conditions of method critical parameter (e.g., times, temperatures,
concentrations) variation. Disturbances of method parameters should reflect maximum
excursions to be expected in practical use. Performance requirements should be met at each
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of these excursions. The statistical design should be capable of measuring at least main
effects.
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Conclusions
The purpose of a qualitative BIM is to discriminate between acceptable target material and
target material with an unacceptable concentration of non-target material. This concept was
particularized to discrimination between the SSTM and SITM for the purpose of method
validation. A general overview of the application of the POI model and analysis was given,
which allows validation and/or characterization of qualitative BIMs. Examples are given for
both SLV and collaborative studies with MPRs. The use of POI statistics harmonizes
statistical concepts among botanical, microbiological, toxin, and other analyte identification
or detection methods for which binary results are obtained. The POI statistical model
provides a tool for graphical representation of response curves for qualitative methods,
reporting of descriptive statistics, and application of performance requirements.
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Appendix A: SIMCA
Principal component analysis (PCA) is a mathematical procedure used to convert
observations for samples with a large number of possibly correlated variables (ions,
wavelength, or wavenumbers) into a set of uncorrelated variables called principal
components (A1). The transformation takes place in manner that assigns the maximum
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variance to the first principal component with less variance being accounted for by each
successive principal component. PCA is applied to the entire data set to determine what
groupings of the samples can be seen without any prior decisions (i.e., it is unsupervised).
The first two or three principal components (displayed as two- or three-dimensional plots)
can be used to demonstrate general patterns in the data.
SIMCA is a supervised approach that builds a PCA model for each specified category of
samples (A2). Distances between the models are then used to determine the independence of
each category of samples. New samples can be assigned to one of the categories or classified
as not fitting in any of them.
SIMCA is used for BIMs because predetermined categories of samples are established and
modeled. For a BIM, however, only a single PCA model is constructed, and that is for the
samples in the inclusivity panel. All other samples are then evaluated using the PCA model
to determine whether it is described by the inclusivity PCA model or whether it lies a
significant distance from the model, i.e., it does not belong to the inclusivity panel category
of samples.
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Two statistics used to evaluate whether a sample fits the PCA model are the Q residual and
the Hotelling T2 statistic. The Hotelling T2 statistic is the multivariate analog of the
univariate Students’ t statistic. It describes how a sample fits in the model. The Q residual,
also called the squared prediction error, is more commonly used for process control
applications. It describes how far a sample falls outside the model. Some chemometric
programs provide both of these statistics as a means of evaluating the fit of a PCA model to
the data (1).
Figure A1 provides a simplified illustration of the relationship of the two statistics. In this
case, a PCA model is fit to one category of samples (black dots). Since only the first
principal component was used for this model, the model is a straight line. The data have
been mean-centered, so they are centered around the origin, i.e., the intersection of the x and
y-axis. The distribution of each sample with respect to the model is determined by dropping
a line from the sample point perpendicular to the model line. The distance from the point
where the perpendicular of a sample intersects the model line to the origin provides the
Hotelling T2 value for that point. With sufficient data and a normal distribution, the data
distribution should appear as a bell-shaped function centered at the origin. Using this
distribution, it can be determined whether a sample is well-fit by the model, i.e., falls inside
the 95% confidence limits.
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The variance of the sample data with respect to the model is the variance computed along
the straight line. In this case, it would be analogous the Students’ t calculation, i.e., the sum
of square of the distance for each sample. In Figure A1, the first principal component for the
modeled category (black dots) passes through the sample data in a manner that provides the
maximum variance. A second principal component, perpendicular to the first, would account
for the distance of the points from the line and, in this case, provide far less variance than
the first principal component. For a model based just on the first principal component, the
variance associated with the distance of the sample points from the line is accounted for by
the Q residual.
The distribution of unmodeled data from a second category of samples (the red dots) can be
evaluated using the model for the first category of samples. As shown in Figure A1, the
distribution of the second category of samples on the first model is very reasonable.
Perpendicular lines from the samples in the second category intercept the model line at
reasonable distances from the origin. If this were real data, and a 95% confidence limit had
been computed, the second category of samples would undoubtedly be within that limit.
J AOAC Int. Author manuscript; available in PMC 2013 April 08.
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However, for the second category of samples, a much larger fraction of the total variance is
incorporated in the distance from the model line. The second category samples will fall well
outside the 95% confidence limit for the Q residual established by the first category samples.
SIMCA can be applied to a BIM by constructing a PCA model using the data from the
inclusivity panel botanical materials. New samples are fit to the model and the Q residual is
determined. If the Q residual for a sample falls outside the 95% confidence limit, the new
sample is not the same as the target materials. Conversely, if the new sample falls within the
95% confidence limit, it would be classified as a target material.

Appendix B: Modeling of the POI Using Logistic Regression
The models in common use for this kind of problem include, among many others: (1)
discriminant analysis; (2) logistic regression; or (3) normit regression. There is also a choice
of metamer x (i.e., transform of %SSTM). Common choices include x = % SSTM, or x =
log10 (%SSTM + 0.5). Logistic and normit regression assume the POI versus x curve is
symmetrical, which that of Figure 4 obviously is not.
Suppose we choose logistic regression with an identity metamer (x = % SSTM), which
implies the model:
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(Eq. B1)

For the sample data, the fit is as shown in Figure B1:
The model fits poorly and is highly over-dispersed (dispersion = 10.908 / 2 = 5.454).
Consequently, the standard errors found in the fit should be multiplied by 2.34 = √5.454.
(Note that this over-dispersion suggests that the logistic regression model with specified link
is a poor choice for the data.)
An estimate of the point at which POI = 0.5000 is given by the negative ratio of the intercept
by the slope, or x = 64.1% SSTM. This would be denoted “Effective Concentration at POI =
0.50” or “EC50.” (It should be noted that EC50 depends upon the definitions of the SSTM
and SITM.)
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From the logistic regression fit, we get the results shown in Table B1 and Figure B2. The
logistic regression does not do as well as the direct POI descriptive statistics of Table 6,
because of serious failure of the model assumptions. (It turns out that none of the usual
generalized model forms fits the asymmetrical POI versus % SSTM curve very well for this
example. So it should be noted that the standard error of POI is not always reduced by fitting
across the combination of concentrations used.) Note that, based on the logistic model, the
BIM continues to pass the 0% SSTM performance requirement, but fails the 100% SSTM
requirement.
It is generally recommended that the methods of Table 6 be used for evaluating performance
requirements, rather than those of unvalidated regression models. One of the advantages,
however, of fitting such a model is that continuous curves may be obtained, as shown in
Figure B3.
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Figure 1.

Probability of identification for botanical identification.

NIH-PA Author Manuscript
J AOAC Int. Author manuscript; available in PMC 2013 April 08.

LaBudde and Harnly

Page 15

NIH-PA Author Manuscript
NIH-PA Author Manuscript

Figure 2.

Inclusivity/exclusivity and SSTM/SITM characterization.

NIH-PA Author Manuscript
J AOAC Int. Author manuscript; available in PMC 2013 April 08.

LaBudde and Harnly

Page 16

NIH-PA Author Manuscript
NIH-PA Author Manuscript

Figure 3.

Conversion of SSTM, SITM, and intermediate concentrations to POI.
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Figure 4.

SIMCA plots for (A) 100% American ginseng (AG) and 100% Asian ginseng (CG); (B)
SSTM, 100% AG, and 100% CG; and (C) SITM, 100% AG, and 100% CC. Legend: Red =
AG, Green = CG, and Blue = (B) SSTM and (C) SITM.
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Figure 5.

Target material AG, non-target material CG: (A) SITM and SSTM, and (B) POI.
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Figure 6.

Expected POI versus %SSTM for an example BIM showing POI (solid line), lower 95%
confidence limit (dashed line below the POI), and upper 95% confidence limit (dashed line
above the POI). Note the POI at 0% is the false-positive fraction and 1-POI at 100% is the
false-negative fraction.
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Figure A1.

Illustration of Hotelling T2 and Q statistic: (*) modeled samples and (*) unknown samples.
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Figure B1.

Fit of Eq. B1 to the sample data.
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Figure B2.

Example SLV results from a logistic regression fit showing POI (solid line), lower 95%
confidence limit (dashed line below the POI), and upper 95% confidence limit (dashed line
above the POI).
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Figure B3.

Continuous curves from SLV logistic regression fit showing POI (solid line), lower 95%
confidence limit (dashed line below the POI), and upper 95% confidence limit (dashed line
above the POI).
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Table 1

Panax samples analyzed in this study
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No.

Label

Provider

Source

Inclusivity panel (American ginseng)
26

American ginseng

USA

13

American ginseng

USA

4

American ginseng

USA
Exclusivity panel (Chinese ginseng)

3

Asian ginseng, red

American Herbal Pharmacopoeia 2

China

1

Kirin Red No. 1

Internet retailer

China

1

Kirin Red No. 3

Internet retailer

China

1

Kirin Red No. 5

Internet retailer

China

1

Shih Chu No. 25

Internet retailer

China

1

Shih Chu No. 80

Internet retailer

China
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COLUMN
HEADER?

COLUMN HEADER?

COLUMN HEADER?

SSTMa

344

0.98 American ginseng + 0.02 Asian ginseng

SITMa

344

0.90 American ginseng + 0.10 Asian ginseng

a

In each case, each of the 43 American ginseng samples were mixed with each of the eight Asian ginseng samples (43 × 8 = 344).
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0

POI

95% 1-sided UCL

95% 1-sided LCL

Measure

In each case, no more than two failures are allowed.

a

100

SSTM, %

POI

Requirement

0.10 (FPF<0.10)

0.90 (FNF<0.10)

Limit

60

60

No. of replicates to
be tested
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Example performance requirements

2

2

No. of failures alloweda
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48
72
40
48
60
72
60
72

0.15

0.15

0.10

0.10

0.10

0.10

0.05

0.05

0.010

0.018

0.020

0.045

0.036

0.043

0.100

0.096

0.088

0.063

0.136

0.146

0.115

0.101

0.119

0.187

0.199

0.191

0.167

0.196

0.197

1-sided 95%
UCLd

Desired maximum level of FNF or FPF to attain with 95% confidence.

0

1

0

1

0

0

3

2

1

0

5

3

1

0

0

8

5

3

1

1

0

No. of failures
allowedc

0.000

0.000

0.000

0.000

0.000

0.000

0.014

0.009

0.000

0.000

0.030

0.021

0.000

0.000

0.000

0.057

0.045

0.029

0.000

0.000

0.000

2-sided 95% LCLe

95% modified Wilson 2-sided confidence interval on FNF or FPF if maximum failures are observed.

e

Worst-case 1-sided 95% modified Wilson upper confidence limit on FNF or FPF if maximum failures are observed.

d

0.014

0.023

0.029

0.057

0.051

0.060

0.115

0.114

0.109

0.088

0.152

0.168

0.142

0.138

0.161

0.204

0.222

0.218

0.202

0.236

0.259

2-sided 95% UCLe

Maximum number of failures that can occur in the replicates tested and still meet specification.

c

b

Excerpted from LaBudde (5).

a

36

0.15

280

24

0.15

240

20

0.15

0.01

72

0.20

0.02

48

0.20

96

36

0.20

130

24

0.20

0.02

20

0.20

0.05

11

No. of replicates
to be tested

0.20

Specified
maximumb

0.007

0.012

0.014

0.028

0.025

0.030

0.065

0.061

0.054

0.044

0.091

0.095

0.071

0.069

0.081

0.131

0.133

0.124

0.101

0.118

0.129

AOQLf

Alternative test plans to obtain 1-sided upper 95% modified Wilson confidence limit at or below specified maximum value for FNF or FPFa
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f
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Observed FNF or FPF corresponding to maximum failures allowed.
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Table 4

Observed SLV results for example BIM
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No. of test
portions

No.
dentified

No. not
identified

POI

0.0

60

1

59

0.0167

33.3

60

7

53

0.1167

66.7

60

27

33

0.4500

100.0

60

60

0

1.0000

SSTM, %
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n

60

60

60

60

0.0

33.3

66.7

100.0

60

27

7

1

ID

0

33

53

59

Not ID

1.0000

0.4500

0.1167

0.0167

POI
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SSTM, %

0.9568

0.0713

1-sided 95%

0.9398

0.3309

0.0577

0.0000

LCL 95%

1.0000

0.5751

0.2218

0.0886

UCL 95%
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Reported SLV results
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Table 6

Collaborative study results
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Collaborator

Replicates

No. identified

0

1

12

1

0

2

12

0

0

3

12

0

0

4

12

0

0

5

12

0

0

6

12

0

0

7

12

0

0

8

12

0

0

9

12

0

0

10

12

0

33.33

1

12

2

33.33

2

12

2

33.33

3

12

2

33.33

4

12

2

33.33

5

12

0

33.33

6

12

1

33.33

7

12

1

33.33

8

12

4

33.33

9

12

2

33.33

10

12

3

66.67

1

12

4

66.67

2

12

9

66.67

3

12

5

66.67

4

12

8

66.67

5

12

7

66.67

6

12

4

66.67

7

12

7

66.67

8

12

3

66.67

9

12

8

66.67

10

12

5

100

1

12

12

100

2

12

10

100

3

12

11

100

4

12

12

100

5

12

12

100

6

12

11

100

7

12

12

100

8

12

12

100

9

12

12
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Collaborator

Replicates

No. identified

10

12

12
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Homogeneity test of laboratory PODs
Reproducibility SD

Intraclass correlation coefficient for repeatability

6

7

8

UCL = Upper confidence level.

b

LCL = Lower confidence level.

a

Repeatability SD
Among-laboratories SD

5

3

4

Total number of replicates

Overall mean of all data (grand mean)

2

Total number of laboratories

Item

1

Sequence

Sample ID 0% SSTM

l(r)

s(R)

P-value

s(L)

s(r)

LPOI or LPOD

Sum(n(L))

p

Symbol

AOAC Binary Data Interlaboratory Study Workbook Study Reported Values

1.0000

0.0913

0.4303

0.0000

0.0913

0.0083

120

10

Value

0.8335

0.0814

0.0000

0.0807

0.0015

Approximately
95% LCLa

1.0000

0.1064

0.0402

0.1713

0.0457

Approximately
95% UCLb

Version: 2.2
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Collaborative study results for 0% SSTM concentration
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Total number of replicates

Overall mean of all data (grand mean)

Repeatability SD

Among-laboratories SD

Homogeneity test of laboratory PODs

Reproducibility SD

Intraclass correlation coefficient for repeatability

3

4

5

6

7

8

Total number of laboratories

1

2

Item

Sequence

Sample ID 33.33% SSTM

l(r)

s(R)

P-value

s(L)

s(r)

LPOI or LPOD

Sum(n(L))

p

Symbol

AOAC Binary Data Interlaboratory Study Workbook Study Reported Values

1.0000

0.3703

0.6563

0.0000

0.3703

0.1583

120

10

Value

0.8889

0.3304

0.0000

0.3272

0.0913

Approximately
95% LCL

1.0000

0.4275

0.1400

0.4266

0.2253

Approximately
95% UCL

Version 2.2
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Collaborative study results for 33.33% SSTM concentration
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Total number of replicates

Overall mean of all data (grand mean)

Repeatability SD

Among-laboratories SD

Homogeneity test of laboratory PODs

Reproducibility SD

Intraclass correlation coefficient for repeatability

3

4

5

6

7

8

Total number of laboratories

1

2

Item

Sequence

Sample ID 66.67% SSTM

l(r)

s(R)

P-value

s(L)

s(r)

LPOI or LPOD

Sum(n(L))

p

Symbol

AOAC Binary Data Interlaboratory Study Workbook Study Reported Values

0.9644

0.5029

0.1783

0.0948

0.4939

0.5000

120

10

Value

0.7547

0.4489

0.0000

0.4364

0.3919

Approximately
95% LCL

1.0000

0.5222

0.2779

0.5222

0.6081

Approximately
95% UCL

Version 2.2

NIH-PA Author Manuscript

Collaborative study results for 66.67% SSTM concentration
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Total number of replicates

Overall mean of all data (grand mean)

Repeatability SD

Among-laboratories SD

Homogeneity test of laboratory PODs

Reproducibility SD

Intraclass correlation coefficient for repeatability

3

4

5

6

7

8

Total number of laboratories

1

2

Item

Sequence

Sample ID 33.33% SSTM

l(r)

0.9772

0.1804

0.2506

s(R)

0.0273

s(L)

0.1784

0.9667

120

10

Value

P-value

s(r)

LPOI or LPOD

Sum(n(L))

p

Symbol

AOAC Binary Data Interlaboratory Study Workbook Study Reported Values

0.7818

0.1610

0.0000

0.1576

0.9174

Approximately
95% LCL

1.0000

0.2121

0.0930

0.2055

0.9870

Approximately
95% UCL

Version 2.2

NIH-PA Author Manuscript

Collaborative study results for 100.0% SSTM concentration
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0.0816

0.5511

33.3%

66.7%

0.9443

0.0064

0.0%

100.0%

POI

% SSTM

Fitted

1.0000

0.4500

0.1167

0.0167

POI

Obs.

0.7715

0.0778

95%

1-sided

0.7126

0.3181

0.0162

0.0003

95%

LCL

0.9915

0.7636

0.3239

0.1214

95%

UCL
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